Laddar...
Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
The estrogen receptor-alpha (ERα) is used as a predictive marker for anti-estrogen therapy in breast cancer patients. In addition to aromatase inhibitors, ERα can be targeted at the receptor level using the receptor modulator tamoxifen or by the pure anti-estrogen fulvestrant. The role of the second...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302959/ https://ncbi.nlm.nih.gov/pubmed/27486755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10871 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|